Infant Vaccine Study
Participants needed: Two month old infants
About pneumococcal disease
Pneumococcal disease is caused by the bacteria Streptococcus pneumoniae.
This bacteria can cause very severe infections such as bacteremia (blood poisoning), meningitis (brain infection) and pneumonia, and less severe infections like ear and sinus infections.
Without vaccination, children under two years of age have the highest rates of disease.
What is the purpose of this study?
The purpose of the study is to find out if two doses of pneumococcal vaccine (PCV) – Prevnar13®is as good as three doses (which is currently used in NS and most other provinces/territories in Canada) in protecting children against pneumococcal disease.
We would like to find out if it is possible to achieve the same protection against pneumococcal infection using just two injections, at two and 12 months.
This would reduce the number of needles needed for infants in the future, and result in significant cost savings across Canada.
Is my child eligible to participate?
We are in need of healthy, two-month old infants.
The study involves six visits over an 11-month period.
Your child is seen at CCfV when your child is 2, 4, 5, 6, 12, and 13 months old.
Visits will include three blood tests (total), routine vaccinations, physical exams, and questions about your baby’s health.
You will receive:
Reimbursement for your out of pocket expenses related to the study such as travel and parking.
Study staff will be giving all routine infant vaccinations up to 12 months of age.
We will send documentation to you and to Public Health and record these vaccines on the child’s vaccination record.
Contact Pamela MacIntyre
Phone (902) 470-8948